Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLK7 | P49862 | 2/20 | 0.51 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.51 |
| ▸ | SIRT2 | Q8IXJ6 | 11/20 | 0.49 |
| ▸ | SIRT1 | Q96EB6 | 10/20 | 0.49 |
| ▸ | SIRT5 | Q9NXA8 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | SIRT3 | Q9NTG7 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12518535 | 1.00 | KLK7 (0.51) | KLK7KLK5SIRT2SIRT1SIRT5 | |
| SCHEMBL12516829 | 1.00 | KLK7 (0.51) | KLK7KLK5SIRT2SIRT1SIRT5 | |
| SCHEMBL21372036 | 0.99 | KLK7 (0.51) | KLK7KLK5SIRT2SIRT1SIRT5 | |
| SCHEMBL15317949 | 0.97 | KLK7 (0.48) | KLK7KLK5SIRT2SIRT1SIRT5 | |
| SCHEMBL12778935 | 0.97 | KLK7 (0.48) | KLK7KLK5SIRT2SIRT1SIRT5 | |
| SCHEMBL12778910 | 0.97 | KLK7 (0.48) | KLK7KLK5SIRT2SIRT1SIRT5 | |
| SCHEMBL12778926 | 0.97 | KLK7 (0.48) | KLK7KLK5SIRT2SIRT1SIRT5 | |
| SCHEMBL12779163 | 0.97 | KLK7 (0.54) | KLK7KLK5SIRT2SIRT1SIRT5 | |
| SCHEMBL12780067 | 0.96 | KLK7 (0.51) | KLK7KLK5SIRT2SIRT1SIRT5 | |
| SCHEMBL12518233 | 0.94 | KLK7 (0.52) | KLK7KLK5SIRT2SIRT1SIRT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150197485-A1 | Processes For Preparing A Polymeric Compound | CELLCEUTIX CORP (US) | 2015-07-16 | — | — | US | disclosed |
| US-8946475-B2 | Processes for preparing a polymeric compound | CELLCEUTIX CORPORATION (US) | 2015-02-03 | — | — | US | disclosed |
| US-20130274502-A1 | Processes For Preparing A Polymeric Compound | POLYMEDIX, INC. (US) | 2013-10-17 | — | — | US | disclosed |
| WO-2011050162-A1 | PROCESSES FOR PREPARING A POLYMERIC COMPOUND | POLYMEDIX, INC. (US) | 2011-04-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150197485-A1 | Processes For Preparing A Polymeric Compound | F12, ALG1, ABCB11 | KLK7 764/4885KLK5 359/4885SIRT2 3254/4885 |
| US-20130274502-A1 | Processes For Preparing A Polymeric Compound | F12, ALG1, ABCB11 | KLK7 764/4885KLK5 359/4885SIRT2 3254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.